- Report
- August 2025
- 187 Pages
Global
From €3171EUR$3,545USD£2,745GBP
€3524EUR$3,939USD£3,051GBP
- Report
- August 2025
- 142 Pages
Global
From €2650EUR$2,963USD£2,294GBP
€3533EUR$3,950USD£3,059GBP
- Report
- April 2025
- 100 Pages
Canada
From €4428EUR$4,950USD£3,833GBP
- Report
- July 2024
- 120 Pages
Global
From €4249EUR$4,750USD£3,679GBP
- Report
- September 2025
- 96 Pages
Global
From €3500EUR$4,191USD£3,136GBP
- Report
- March 2026
- 50 Pages
Global
From €2371EUR$2,650USD£2,052GBP
Iodixanol is a non-ionic, low-osmolar contrast medium used in medical imaging. It is used to enhance the visibility of organs and tissues during X-ray, computed tomography (CT), and magnetic resonance imaging (MRI) scans. It is also used to diagnose and treat certain medical conditions. Iodixanol is a member of the class of contrast media known as iodinated contrast agents, which are used to improve the visibility of organs and tissues during imaging procedures.
Iodixanol is a safe and effective contrast medium that is well tolerated by patients. It is available in a variety of formulations, including injectable solutions, oral solutions, and suspensions. It is also available in a variety of concentrations, allowing for the adjustment of the dose to the patient's needs.
Iodixanol is widely used in medical imaging and is available from a number of manufacturers, including GE Healthcare, Bayer, Bracco, Guerbet, and Mallinckrodt. Show Less Read more